Risk of suicide among users of calcium channel blockers: Population based, nested case-control study

British Medical Journal

Volumn 320, Issue 7244, 2000, Pages 1251-

  Gasse, Christiane ^a   Derby, Laura E ^a   Vasilakis, Catherine ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; METHYLDOPA; VASODILATOR AGENT;

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; SUICIDE;

ADRENERGIC BETA-ANTAGONISTS; BODY MASS INDEX; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; DIURETICS; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; LOGISTIC MODELS; MENTAL DISORDERS; RISK ASSESSMENT; SUICIDE;

EID: 0034611907     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. 1 Lindberg G, Bingefors K, Ranstam J, Ranstam L, Melander A. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study. BMJ 1998;316:741-5.
2. 2 Bergman U, Isacsson G. Use of calcium channel blockers and risk of suicide. BMJ1998;317:1076.
3. 3 Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
4. 4 Derby LE, Jick H, Dean AD. Antidepressant drugs and suicide. J Clin Psychopharmacol 1992;12:235-40.